Nuplazid
Chemical Name | pimavanserin |
Dosage Form | Tablet (oral; 10 mg); Capsule (oral; 34 mg) |
Drug Class | Antipsychotics |
System | Nervous |
Company | Acadia Pharmaceuticals Inc. |
Approval Year | 2016 |
Indication
- To treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.